Enanta Pharmaceuticals Inc (ENTA)
Operating Cash Flow Growth
-52.34%
TTM · Period ending:
ENTA Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-52.34%period ending
Latest reported-52.34%period ending
ENTA TTM Cash from Operations YoY % (-44.63% → -52.34%)
Year-over-year change
High-resolution chart · PNG
ENTA operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -52.3358% | |
| 85.8683% | |
| 79.9226% | |
| 75.532% | |
| 74.2314% | |
| 48.3186% | |
| 23.7014% | |
| 23.6443% | |
| 7.3337% | |
| -13.493% | |
| 13.6731% | |
| -21.6697% | |
| -7.5519% | |
| -4.8651% | |
| -56.7077% | |
| -21.1241% | |
| -40.0909% | |
| -128.761% | |
| -239.0875% | |
| -1,087.5282% | |
| -307.2297% | |
| -203.4186% | |
| -137.6726% | |
| -90.0753% | |
| -65.9109% | |
| -58.8964% | |
| -2.7931% | |
| 144.4148% | |
| 56.7655% | |
| 87.935% | |
| 2.1292% | |
| -44.5046% | |
| 958.3124% | |
| 1,304.9084% | |
| 501.6851% | |
| 47.0385% | |
| -119.0636% | |
| -117.4485% | |
| -92.0188% | |
| -53.2965% | |
| -52.0212% | |
| -80.9861% | |
| 449.2955% | |
| 279.9643% | |
| 227.8309% | |
| 769.8741% | |
| 579.4745% | |
| 89.4208% | |
| 97.3808% | |
| -236.0053% | |
| -112.2303% | |
| -52.9108% | |
| -44.6265% |